Company / Interest Expense per Share
ABEONA THERAPEUTICS INC. Interest Expense per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.08
FY2025
5-year range
$0.02 / $0.62
FY2021-FY2025
Trend
+419.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed +420% YoY in FY2025, a notable deviation from the 4-year average annual change of +404%.
Based on SEC 10-K filings.
0.08 in FY2025 with a 3-year CAGR of -49.1%.
Increased from $0.04 to $0.08 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -49.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share increased 419.9% year-over-year.
- Peak interest expense per share was recorded in FY2022.
- Lowest interest expense per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | +419.9% |
| FY2024 | $0.02 | -62.1% |
| FY2023 | $0.04 | -93.3% |
| FY2022 | $0.62 | +1350.5% |
| FY2021 | $0.04 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026